Skip to main content
Jeffrey Tosoian, MD, Urology, Nashville, TN

JeffreyJohnTosoianMD

Urology • Nashville, TN

Asst. Prof., Director of Translational Cancer Research, Urologic Oncology Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center

Join to view full profile

Dr. Tosoian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tosoian's full profile

Already have an account?

  • Office

    3601 The Vanderbilt Clinic
    Nashville, TN 37232
    Phone+1 615-322-3000

Education & Training

  • University of Michigan Medical Center
    University of Michigan Medical CenterTranslational Cancer Research, Urologic Oncology, 2018 - 2021
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Urology, 2012 - 2018
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2012, MD, MPH

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2021 - 2025
  • MI State Medical License
    MI State Medical License 2018 - 2022
  • Urology
    American Board of Urology Urology
  • Urology
    American Board of UrologyUrology

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy from a Statewide Improvement Collabora...  
    Gregory B Auffenberg, Jeffrey Tosoian, Richard Sarle, William K Johnston, Eduardo Kleer, Khurshid R Ghani, James Montie, JAMA Surgery
  • Association of Tumor-Infiltrating T-cell Density with Molecular Subtype, Racial Ancestry and Clinical Outcomes in Prostate Cancer  
    Tamara L Lotan, Edward M Schaeffer, Jeffrey J Tosoian, Scott A Tomlins, Nature

Authored Content

  • The Androgen Signaling Axis and Risk Stratification for High-Grade Prostate CancerMarch 2018
  • Risk Stratification in Active Surveillance: A Dynamic, Ever-Evolving PracticeFebruary 2018

Press Mentions

  • Males Who Skip Prostate Screenings Could Face 45% Higher Risk of Death: Study
    Males Who Skip Prostate Screenings Could Face 45% Higher Risk of Death: StudyMarch 27th, 2025
  • Lifesaving at-Home Urine Test Detects Prostate Cancer with 94% Accuracy
    Lifesaving at-Home Urine Test Detects Prostate Cancer with 94% AccuracyMarch 26th, 2025
  • Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer
    Urine-Based Test Provides Accurate Testing Option for Advanced Prostate CancerFebruary 12th, 2025
  • Join now to see all

Grant Support

  • Michigan-VUMC Biomarker Characterization CenterUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027

Dr. Jeffrey Tosoian, Dr. Jeffrey Tosoian, MD, Dr. J Tosoian, Dr. Jeffrey John Tosoian